Detalhe da pesquisa
1.
Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic Cancer.
N Engl J Med
; 388(1): 33-43, 2023 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36546651
2.
Intratumoral Cell Neighborhoods Coordinate Outcomes in Pancreatic Ductal Adenocarcinoma.
Gastroenterology
; 2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38244727
3.
Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors.
Br J Cancer
; 129(2): 309-317, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37237172
4.
A Real-World Comparison of Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer in the United States.
J Natl Compr Canc Netw
; 21(3): 257-264, 2023 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36812939
5.
Anal Carcinoma, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(6): 653-677, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37308125
6.
Epacadostat Plus Pembrolizumab and Chemotherapy for Advanced Solid Tumors: Results from the Phase I/II ECHO-207/KEYNOTE-723 Study.
Oncologist
; 27(11): 905-e848, 2022 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36156099
7.
Treatment outcomes in recurrent versus de novo metastatic pancreatic adenocarcinoma: a real world study.
BMC Cancer
; 22(1): 1054, 2022 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36224524
8.
Treatment Trends and Clinical Outcomes of Left-Sided RAS/RAF Wild-Type Metastatic Colorectal Cancer in the United States.
J Natl Compr Canc Netw
; 20(3): 268-275, 2022 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35120306
9.
Real-World Outcomes of Patients With BRAF-Mutated Metastatic Colorectal Cancer Treated in the United States.
J Natl Compr Canc Netw
; 20(2): 144-150, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35130499
10.
Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(10): 1139-1167, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36240850
11.
Clinical Development of Anti-TIGIT Antibodies for Immunotherapy of Cancer.
Curr Oncol Rep
; 24(9): 1107-1112, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35412226
12.
A Phase I, First-in-Human Study of GSK2849330, an Anti-HER3 Monoclonal Antibody, in HER3-Expressing Solid Tumors.
Oncologist
; 26(10): e1844-e1853, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34132450
13.
Refusal of Local Therapy in Esophageal Cancer and Impact on Overall Survival.
Ann Surg Oncol
; 28(2): 663-675, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32648178
14.
Clinical Activity of Selitrectinib in a Patient With Mammary Analogue Secretory Carcinoma of the Parotid Gland With Secondary Resistance to Entrectinib.
J Natl Compr Canc Netw
; 19(5): 478-482, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34030125
15.
Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 19(3): 329-359, 2021 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33724754
16.
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials.
Lancet Oncol
; 21(2): 271-282, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31838007
17.
NCCN Guidelines Insights: Rectal Cancer, Version 6.2020.
J Natl Compr Canc Netw
; 18(7): 806-815, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32634771
18.
First-in-human, phase I study of PF-06647263, an anti-EFNA4 calicheamicin antibody-drug conjugate, in patients with advanced solid tumors.
Int J Cancer
; 145(7): 1798-1808, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30680712
19.
Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation Burden.
Oncologist
; 24(2): 219-228, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30108156
20.
Phase I/II study of everolimus combined with mFOLFOX-6 and bevacizumab for first-line treatment of metastatic colorectal cancer.
Invest New Drugs
; 37(3): 482-489, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30302599